Refresh

Somerset Therapeutics Ltd. - Research Center

524758 WINTAC Group (XT) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17 Mar ' 16
Income

Operating income

85.11 71.92 44.35 32.80 18.10
Expenses

Material consumed

35.94 27.33 18.38 13.78 8.88

Manufacturing expenses

8.36 5.70 4.39 4.08 3.19

Personnel expenses

27.69 23.25 17.99 15.03 12.88

Selling expenses

0.02 - 0.01 0.01 0.01

Adminstrative expenses

10.34 12.27 9.56 7.23 6.65

Expenses capitalised

- - - - -

Cost of sales

82.34 68.54 50.32 40.14 31.63

Operating profit

2.77 3.38 -5.97 -7.34 -13.53

Other recurring income

2.76 1.95 0.72 1.11 0.18

Adjusted PBDIT

5.53 5.33 -5.25 -6.23 -13.34

Financial expenses

1.91 0.93 0.90 1.00 0.74

Depreciation

7.24 4.18 3.55 3.63 3.87

Other write offs

- - - - -

Adjusted PBT

-3.62 0.21 -9.70 -10.86 -17.95

Tax charges

-0.56 0.10 0.09 -1.21 -1.21

Adjusted PAT

-3.06 0.11 -9.79 -9.65 -16.74

Non recurring items

-0.72 -0.27 -0.10 1.13 1.61

Other non cash adjustments

- - - - -

Reported net profit

-3.79 -0.16 -9.90 -8.52 -15.13

Earnigs before appropriation

-73.28 -69.50 -69.34 -59.44 -51.00

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-73.28 -69.50 -69.34 -59.44 -51.00
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com